SCHEMBL14067378

SCHEMBL14067378

CON1C(C)(C)CC(CO)C1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8739036 0.75 APLNR (0.39)
SCHEMBL21102819 0.74
SCHEMBL4853121 0.72 GAA (0.52)
SCHEMBL14192911 0.72 GAA (0.52)
SCHEMBL21102697 0.71
SCHEMBL2992832 0.71 ADORA3 (0.36)
Hydrochloric Acid SCHEMBL4960439 0.71 GAA (0.50)
SCHEMBL13333461 0.71
Hydrochloric Acid SCHEMBL4436968 0.69 GAA (0.48)
SCHEMBL21102844 0.68 ATM (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008109740-A2 MITOCHONDRIA TARGETED CATIONIC ANTI-OXIDANT COMPOUNDS FOR PREVENTION, THERAPY OR TREATMENT OF HYPER-PROLIFERATIVE DISEASE, NEOPLASIAS AND CANCERS COLBY PHARMACEUTICAL COMPANY (US) 2008-09-12 WO disclosed